My Natural Treatment – FDA Warning Letter, Feb 11, 2022
On February 22, 2022, the FDA and FTC issued a Warning Letter to MyNaturalTreatment.com for promoting unapproved and misbranded products related to COVID-19. The review of their website and Facebook page on January 18 and February 11, 2022, revealed that as an Amazon Associate, they promoted thyme, black seed, eucalyptus, rosemary, and peppermint oils with claims implying they could mitigate, prevent, treat, diagnose, or cure COVID-19.
These claims render the products unapproved new drugs under FD&C Act Section 505(a) and misbranded drugs under Section 502. The introduction or delivery of these products into interstate commerce is prohibited under Sections 301(a) and (d), and misbranding while held for sale after interstate shipment is prohibited under Section 301(k).
The letter cited specific claims, such as "How to Make Your Own Natural Antiviral for COVID-19" and descriptions of essential oils as "natural antiviral for Covid-19." The FDA requested immediate cessation of sales of these unapproved products and a response within 48 hours detailing corrective actions and preventative measures. Failure to comply could result in legal action, including seizure and injunction. The firm will be added to the FDA's public list of firms with COVID-19 related warning letters.
The FTC also stated that advertising products to
ID · 4291ece1-bf50-4fe9-a0dc-a4884d5657a6
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.